Fatty Liver

"Fatty Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Descriptor ID	D005234
MeSH Number(s)	C06.552.241
Concept/Terms	Fatty Liver Fatty Liver Liver, Fatty Steatohepatitis Steatohepatitis Steatohepatitides Steatosis of Liver Visceral Steatosis Steatoses, Visceral Steatosis, Visceral Visceral Steatoses Liver Steatosis Liver Steatoses Steatoses, Liver Steatosis, Liver

Below are MeSH descriptors whose meaning is more general than "Fatty Liver".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Fatty Liver [C06.552.241]

Below are MeSH descriptors whose meaning is more specific than "Fatty Liver".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fatty Liver" by people in this website by year, and whether "Fatty Liver" was a major or minor topic of these publications.

Bar chart showing 41 publications over 20 distinct years, with a maximum of 6 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2006	1	0	1
2007	1	0	1
2008	2	1	3
2009	1	0	1
2010	1	0	1
2011	2	1	3
2012	3	1	4
2013	3	1	4
2014	0	1	1
2017	1	1	2
2018	2	0	2
2019	1	0	1
2020	1	0	1
2021	1	1	2
2022	1	0	1
2023	2	0	2
2024	3	3	6
2025	1	0	1
2026	3	0	3

Below are the most recent publications written about "Fatty Liver" by people in Profiles.

Thai NQN, Chun LF, Newton KP, Wilson L, Xanthakos SA, Behling C, Salem RM, Bandoli G, Alcaraz J, Crespo N, Schwimmer JB. Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Cohort Study. Diabetes Care. 2026 Apr 01; 49(4):598-606.

View in: PubMed
Choi J, Han KD, Lee SR, Lee KY, Ahn HJ, Kim B, Oh S, Lip GYH, Choi EK. The influence of menopausal phase on atrial fibrillation risk in steatotic liver disease patients: a nationwide cohort study. Sci Rep. 2026 Feb 10; 16(1).

View in: PubMed
Miyatani Y, Ogawa A, Sempokuya T, Tran C, James D, Seto T, Shikuma C, Kuwada SK. Ethnic disparities in metabolic dysfunction-associated steatotic liver disease and clinical outcomes. Front Endocrinol (Lausanne). 2025; 16:1739137.

View in: PubMed
Bazargan-Hejazi S, Hines C, Usmani M, Argueta C, Pan D, Brown AF. Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data. J Racial Ethn Health Disparities. 2026 Apr; 13(2):1083-1093.

View in: PubMed
Kathuria I, Prasad A, Sharma BK, Aithabathula RV, Ofosu-Boateng M, Gyamfi MA, Jiang J, Park F, Singh UP, Singla B. Nidogen 2 Overexpression Promotes Hepatosteatosis and Atherosclerosis. Int J Mol Sci. 2024 Nov 28; 25(23).

View in: PubMed
Jun H, Liu S, Knights AJ, Zhu K, Ma Y, Gong J, Lenhart AE, Peng X, Huang Y, Ginder JP, Downie CH, Ramos ET, Kullander K, Kennedy RT, Xu XZS, Wu J. Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitis. PLoS Biol. 2024 Jul; 22(7):e3002728.

View in: PubMed
Yamada A, Watanabe A, Nara A, Ishimaru N, Maeda K, Ido Y, Kotake K, Asano M, Shinohara Y, Yamamoto T. Longitudinal Analysis of Mitochondrial Function in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. Int J Mol Sci. 2024 Jun 04; 25(11).

View in: PubMed
Rivera JC, Espinoza-Derout J, Hasan KM, Molina-Mancio J, Mart?nez J, Lao CJ, Lee ML, Lee DL, Wilson J, Sinha-Hikim AP, Friedman TC. Hepatic steatosis induced by nicotine plus Coca-Cola? is prevented by nicotinamide riboside (NR). Front Endocrinol (Lausanne). 2024; 15:1282231.

View in: PubMed
Hickman NE, Price M, Crespo NC, Feldstein AE. Correlating neighborhood-level deprivation and pediatric metabolic dysfunction-associated steatotic liver disease. J Pediatr Gastroenterol Nutr. 2024 Jun; 78(6):1355-1363.

View in: PubMed
Nyakundi BB, Wall MM, Yang J. Supplementation of papaya leaf juice has beneficial effects on glucose homeostasis in high fat/high sugar-induced obese and prediabetic adult mice. BMC Complement Med Ther. 2024 Jan 03; 24(1):18.

View in: PubMed

People

Explore

Similar Concepts

Top Journals